冠昊生物,300238,收入构成,报告日期,2020-06-30,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
西大区,2759,412,2347,85.08%,15.96%
其他（补充）,1005,907,98,9.74%,0.67%
南大区,4890,1538,3352,68.55%,22.79%
东大区,7358,1500,5858,79.61%,39.83%
北大区,4349,1296,3053,70.21%,20.76%

冠昊生物,300238,收入构成,报告日期,2019-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,2488,2086,402,16.15%,1.36%
东大区,17017,4356,12661,74.4%,42.71%
南大区,9652,4158,5495,56.93%,18.53%
西大区,5538,1030,4508,81.4%,15.21%
北大区,9093,2514,6579,72.35%,22.19%

冠昊生物,300238,收入构成,报告日期,2019-06-30,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他（补充）,1105,895,210,19%,1.5%
东大区,8609,2374,6235,72.43%,44.59%
西大区,2087,463,1624,77.83%,11.62%
北大区,3564,956,2608,73.18%,18.65%
南大区,5403,2098,3305,61.17%,23.64%

冠昊生物,300238,收入构成,报告日期,2018-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
南大区,9421,2946,6475,68.73%,19.47%
北大区,11473,2964,8509,74.17%,25.59%
西大区,7743,1554,6189,79.93%,18.61%
其他（补充）,1883,1908,-25,-1.32%,-0.07%
东大区,15326,3225,12101,78.96%,36.39%

冠昊生物,300238,收入构成,报告日期,2017-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
北大区,10348,2038,8309,80.3%,25.18%
南大区,8550,2321,6229,72.85%,18.88%
西大区,7120,1331,5790,81.31%,17.55%
其他（补充）,1755,1638,117,6.66%,0.35%
东大区,17263,4713,12550,72.7%,38.04%

冠昊生物,300238,收入构成,报告日期,2016-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
西大区,2880,417,2463,85.52%,9.71%
南大区,12660,3445,9215,72.79%,36.34%
东大区,11535,1781,9755,84.56%,38.47%
北大区,4204,278,3926,93.4%,15.48%

冠昊生物,300238,收入构成,报告日期,2015-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),-- ,473,-473,--,-2.55%
西大区,3885,503,3382,87.05%,18.25%
南大区,3431,1081,2350,68.48%,12.68%
东大区,11490,1821,9669,84.15%,52.19%
北大区,3811,211,3600,94.46%,19.43%

冠昊生物,300238,收入构成,报告日期,2014-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
南大区,2081,250,1831,88%,10.88%
其他(补充),111,36,74,67.15%,0.44%
西大区,3879,310,3569,92%,21.21%
北大区,4561,354,4207,92.23%,25%
东大区,8404,1261,7143,85%,42.46%

冠昊生物,300238,收入构成,报告日期,2014-06-30,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),52,-- ,52,--,0.74%
西大区,1563,212,1351,86.45%,19.13%
南大区,786,173,613,78.02%,8.68%
东大区,3768,397,3371,89.46%,47.73%
北大区,1788,114,1675,93.63%,23.71%

冠昊生物,300238,收入构成,报告日期,2013-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),23,3,20,86.64%,0.13%
西大区,3788,263,3525,93.06%,23.26%
南大区,2016,228,1788,88.7%,11.8%
东大区,6956,1041,5915,85.03%,39.03%
北大区,4068,162,3907,96.03%,25.78%

冠昊生物,300238,收入构成,报告日期,2013-06-30,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),10,-- ,10,--,0.14%
西大区,1724,68,1656,96.06%,23.81%
南大区,733,41,692,94.46%,9.96%
东大区,3183,513,2670,83.89%,38.39%
北大区,1985,59,1926,97.05%,27.7%

冠昊生物,300238,收入构成,报告日期,2012-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),12,0,12,97.52%,0.09%
西大区,3406,320,3087,90.61%,22.59%
南大区,1638,132,1506,91.93%,11.03%
东大区,6295,438,5857,93.04%,42.87%
北大区,3350,151,3199,95.49%,23.42%

冠昊生物,300238,收入构成,报告日期,2012-06-30,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),6,-- ,6,--,0.08%
西大区,1838,145,1694,92.12%,23.04%
东大区,3346,171,3175,94.89%,43.2%
南大区,842,47,795,94.4%,10.81%
北大区,1742,61,1680,96.49%,22.86%

冠昊生物,300238,收入构成,报告日期,2011-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
其他(补充),5,-- ,5,--,0.04%
西大区,2456,205,2251,91.64%,18.66%
南大区,2004,145,1858,92.75%,15.4%
东大区,5503,324,5180,94.12%,42.93%
北大区,2883,112,2771,96.11%,22.96%

冠昊生物,300238,收入构成,报告日期,2011-06-30,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
西大区,984,88,896,91.06%,18.15%
南大区,724,35,689,95.16%,13.95%
东大区,2390,118,2271,95.05%,46.03%
北大区,1115,36,1079,96.75%,21.86%

冠昊生物,300238,收入构成,报告日期,2010-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
西大区,1455,134,0,90.82%,0%
南大区,1823,86,0,95.3%,0%
东大区,4663,419,0,91%,0%
北大区,2321,90,0,96.13%,0%

冠昊生物,300238,收入构成,报告日期,2009-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
西大区,853,35,0,95.86%,0%
南大区,1268,92,0,92.73%,0%
东大区,2932,205,0,93%,0%
北大区,1503,58,0,96.14%,0%

冠昊生物,300238,收入构成,报告日期,2008-12-31,
按地域,收入(万元),成本(万元),利润(万元),毛利率,利润占比
南大区,804,42,0,94.75%,0%
东大区,1949,117,0,94%,0%
北大区,765,37,0,95.12%,0%

